Indian pharma companies have been struggling to maintain margins because of strong headwinds. Due to increased competition, pharma companies are experiencing price erosion in the market, resulting in sluggish growth. While price erosion is not the only issue at hand, China’s lockdown that caused supply chain disruption, the rise in raw material prices, and the Russia-Ukraine war have raised packaging costs.
Asian stocks fall ahead of US non-farm payroll data
Shares in Australia and Japan fell more than 1% in opening trade while equity index futures for Hong Kong slipped. Drops for Japanese benchmarks reflected
March 7, 2025